Stocks
Allogene Therapeutics (ALLO) Net margin US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | LTM ? | CAGR 5 years ? | |||
| Net margin, % | ? | -159.6% | -218 214% | -344 489% | -1 170 864% | ||||
| Changes by years, y/y, % | -218 055pp | -126 275pp | -826 374pp | +1 843.2% | |||||
Allogene Therapeutics. Net margin, %
Allogene Therapeutics. Net margin, changes, pp
Allogene Therapeutics (ALLO) Net margin US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| Net margin, % | ? | -333 227% | -360 145% | -283 123% | -202 857% | -295 455% | ||
| Changes by years, y/y, % | -202 325pp | -273 184pp | -113 433pp | -1 055pp | +37 772pp | |||
| Changes by quarters, q/q, % | -131 425pp | -26 919pp | +77 023pp | +80 266pp | -92 598pp | |||
